Peter Nobel, Chairman of the Nobel Sustainability Trust (NST), and Tracy Wang, Chief Executive Officer of NST, ...

“Things are expensive, and people are a little wary of spending money right now, until it all starts making more sense again, ...

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda® (pembrolizumab) as a first-line therapy ...